With more than 900 abstracts focusing on multiple myeloma (MM), the 2017 annual meeting of the American Society of Hematology (ASH) shows once more the great interest of the myeloma community in identifying new potential targets and developing novel therapeutic strategies for this devastating disease.
(BELG J HEMATOL 2018;9(1):8–11)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
